ArticleNPJ breast cancer2024

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.

Florentine S Hilbers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.